Adicet Bio
ACET
#9600
Rank
โ‚น7.46 B
Marketcap
โ‚น777.39
Share price
2.85%
Change (1 day)
1,500.15%
Change (1 year)

Revenue for Adicet Bio (ACET)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adicet Bio from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A-100%
2022 โ‚น2.06 B185.54%
2021 โ‚น0.72 B-44.69%
2020 โ‚น1.30 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚น5.314 TN/A๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น5.868 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.096 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.618 TN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Hawkins
HWKN
โ‚น99.69 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quaker Houghton
KWR
โ‚น177.10 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA